Mission
TO ADVANCE THE SCIENCE THAT WILL PREDICT, PREVENT, REVERSE, AND CURE DISEASES OF THE IMMUNE SYSTEM SUCH AS AUTOIMMUNE DISEASE, ALLERGY, AND ASTHMA.
Public Charity
BENAROYA RESEARCH INSTITUTE AT VIRGINIA
Based in SEATTLE, WA, BENAROYA RESEARCH INSTITUTE AT VIRGINIA operates as a Public Charity. The organization reported $81.3M in revenue, $80.7M in expenses, $95.5M in total assets for fiscal year 2025. Imperigo tracks 169 reported grant relationships connected to this organization totaling approximately $92.6M.
EIN: 910653422
SEATTLE, WA
Biomedicine & Bioengineering Research
NTEE: H92
Latest filing: 2025
Total Revenue$81.3M
Total Expenses$80.7M
Total Assets$95.5M
Grant Records169
Funding Total$92.6M
Filing Years2021–2025
Where $100 goes at Benaroya Research Institute at Virginia
How Benaroya Research Institute at Virginia divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.
$84
Programs
the work itself
$16
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $84 for programs
$57
Translational immunology and advancements of the immune tolerance network (itn) are highlighted below:funding for the immune tolerance network (itn) was initially awarded to jerry nepom, md, phd, at…
$13
Interventional immunologystudying health to understand diseasein june 2025, a team of bri scientists lead by jane buckner, md, cate speake, phd, megan smithmyer, phd, and alex hu, phd…
$9
Fundamental immunology or basic discoveryunderstanding how targeting specific regulatory cells could lead to new ways to treat systemic lupus erythematosus (sle)in november 2024, steve ziegler, phd, a principal…
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
OPERATING SUPPORT
$10,155,020
PEDIATRIC MEDICAL RESEARCH GRANT SUBAWARD
$791,373
T1D RESEARCH
$452,396
RESEARCH
$314,851
$311,693
Showing up to 5 of 169 total records — full history available with membership.
Officers & Directors
DIRECTOR
Anne Mcnamara Osf
DIRECTOR
Bob Carlile
ASSOCIATE RESEARCH MEMBER
Carmen Mikacenic Md
DIRECTOR
Carolyn Corvi
DIRECTOR
Chuck Arnold
DIRECTOR, CENTER FOR FUNDAMENTAL IMMUNOLOGY
Daniel Campbell Phd
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $81.3M | $80.7M | $95.5M |
| 2024 | $93.6M | $87.5M | $96.0M |
| 2023 | $82.5M | $83.3M | $94.4M |
| 2022 | $94.9M | $83.8M | $100.1M |
| 2021 | $37.8M | $37.1M | $104.0M |
Between 2021 and 2025, reported annual revenue grew from $37.8M to $81.3M (+115%), with total assets most recently reported at $95.5M.
Interactive year-over-year charts and full filing details available with membership.